Registration, Storage and Distribution of Chemicals and Drugs for Pre-Clinical Discovery Evaluation and Development

Please see Amendment 1 in the attachments which:  1) To update SECTION C, SECTION G, SECTION H, SECTION L and the IDIQ-Statement of Work and 2) to extend the proposal due date to 4:00PM (EST) on June 13, 2022.

The National Cancer Institute (NCI) Division of Cancer Treatment and Diagnosis (DCTD) Developmental TherapeuticsProgram (DTP) provides services and resources to the academic and private-sector research communities worldwideto facilitate the discovery and development of new cancer therapeutic agents. NCI seeking support services to operateand maintain the National Cancer Institute's Chemotherapeutic Agents Repository (NCI-CAR). The principal goalsof this contract are 1) to support compound acquisition activities related to the DTP anticancer pre-clinical drugevaluation program which seeks to identify new small molecule therapeutic agents and 2) distribution of chemicalsto intramural and extramural investigators for research purposes. This contract is also responsible for providing aninformational interface with NCI and external investigators that are submitting or requesting research compounds; forupdating of the chemical database which includes chemical, inventor, receiving and shipping information; systematicfile and record keeping both current and archival information related to Repository activities; and reacquisition ofsamples for continued chemical and biological studies.

*Please see attachments for full soliciation